SUBSCRIBE
SUBSCRIBE
News   Job Trends

GPC Biotech AG Slashes 44 Pct of Workforce to Survive; German, US Sites Affected

November 15, 2007 | 
1 min read
FRANKFURT, Nov 15 (Reuters) - GPC Biotech is cutting 44 percent of its workforce, or 103 staff, the German biotech company said on Thursday, after its key prostate cancer drug hope satraplatin failed in a clinical trial.
Job creations Europe
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Merck adds 53 to New Jersey chopping block
September 9, 2026
 · 
91 min read
 · 
BioSpace Editorial Staff
Conceptual origami paper plane pulling business finance growth chart line flying upwards on blue sky background.
Manufacturing
Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision
September 9, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Illustration of businessmen moving a mountain uphill. The men & mountain and background are on separate labeled layers.
Insights
Can Benelux turn scientific strength into larger biotech scale?
September 8, 2026
 · 
4 min read
 · 
Jennifer C. Smith-Parker
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Business
4 CDMOs to consider when outsourcing manufacturing
September 8, 2026
 · 
5 min read
 · 
Angela Gabriel